Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Research and Clinical Diagnostic Tests and Controls
  4. Flu and Virus Testing
  5. COVID Testing Kits
  6. 22181001

LumiraDx SARS-CoV-2 Ag Test

Catalog No. 22181001 Shop All Roche Diagnostics Products
Change view
Click to view available options
Quantity:
48 Test Strips/Pk.
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
22-181-001 48 Test Strips/Pk.
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. 22-181-001 Supplier LumiraDx Supplier No. 10418176001
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy

Description

Microfluidic immunofluorescence assay for direct and qualitative detection of nucleocapsid proteins in nasal swab specimens

  • Features:
    • High-sensitivity, microfluidic immunofluorescence assay for direct and qualitative detection of nucleocapsid proteins in nasal swab specimens from patients suspected of COVID-19 with
    • Results in 12 minutes
    • Uses nasal samples to detect nucleocapsid protein antigen with 97.6 % positive agreement to an EUA approved RT-PCR method within the first 12 days of symptom onset
    • For use with the LumiraDx instrument
  • Includes:
    • 48 LumiraDx test strips
    • 48 extraction buffer vials
    • 48 dropper lids
    • LumiraDx SARS-CoV-2 Ag test quick reference instructions
  • Notes:
    • Test has not been FDA cleared or approved, but has been authorized by FDA under an EUA for use by authorized laboratories; use by laboratories certified under the CLIA, 42 U.S.C. §263a, that meet requirements to perform moderate, high or waived complexity tests
    • Authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
    • Authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens
    • USA only- test is authorized for duration of declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that causes COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner
TRUSTED_SUSTAINABILITY

Specifications

Control Sets Available separately
Clia Complexity Waived
Detectable Analytes SARS-CoV-2 Nucleocapsid Protein Antigen
Type Rapid Test
For Use With (Application) Microfluidic Immunofluorescence
For Use With (Equipment) LumiraDx Instrument
Quantity 48 Test Strips/Pk.
Test Time 12 min.

Authorized under EUA for use by authorized labs, test has not been FDA cleared or approved

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.